Submit An Article
Healthcare Insights welcomes rigorous review and analysis from journalists, clinicians, and industry strategists, as well as authentic, high-impact perspectives from healthcare executives, business leaders, and industry professionals at the forefront of healthcare innovation.
We maintain a selective editorial desk to ensure our readership only receives the highest caliber of insight. Due to our limited seasonal capacity and commitment to thorough editorial review, we prioritize evergreen pieces that offer unique data or unconventional perspectives on market shifts.
All external contributions must undergo a formal editorial review process. Below are our guidelines and the process for moving forward.
If you would like to move forward with the guest contribution process, please reach out to us directly at editor@healthcarein.org with Subject Line: "Guest Contribution". Please include the author's full name, best email address, article category, and proposed article draft with an executive summary. The following terms, policies, and fees apply to all features, and cover our editoral review and listing costs.
Editorial Desk Status: Now Reviewing Q1 2026 Submissions
Editorial Standards & Originality:
Authenticity: All work must be original, exclusive to Healthcare Insights, and written by a named industry professional or subject matter expert. Evidence of substantial artificial intelligence-generated writing may result in a withdrawal from the review process.
Evidence-Based: We prioritize data-driven insights. If you are making a market or clinical claim, it must be cited appropriately.
Alignment: Content must focus on our core pillars: Biopharma, M&A, FDA/NIH policy, Business, or Novel Therapies (CRISPR, Gene Silencing, GLP-1s, etc.), unless otherwise approved by an Editor directly.
Formatting: We do not accept "SEO-first" content. Articles must be written for an audience of executives, researchers, and investors, not search engines.
Listing/Editing Fees:
To cover the costs of peer review, professional editing, and placement within our digital ecosystem, we apply a standard listing review fee. Please find our rates (including placement, listing, and editorial fees) and eligibility as follows:
A: Industry Perspective ($750.00 USD):
- 800+ words, placement in our Industry Voice section, at most 2 high-authority backlinks
B: Deep-Dive/Analysis ($950.00 USD):
- 1,500+ words, data-heavy, featured placement on the homepage for 168 hours (1 week) + placement on 1 weekly newsletter (01/01/2026 onward)
C: White Paper/Report with Executive Summary (PDF) ($1,200 USD):
- 4,000+ words, a full technical report/analysis downloadable as a PDF for readers
Additional Fees (if applicable):
Editorial Partnership Fees: All articles submitted on behalf of a corporation or PR firm are subject to an additional fee of $60.
Expedited Editorial Review: For an expedited review of your submitted pitch and a publication decision within 3 business days, an expedited review will incur an additional fee of $275 at the request of the author.
Disclosure & Transparency: In accordance with industry standards and our transparency values, all guest contributions are labeled as "Partner Insights" or "Contributor Content." Links within the article are tagged according to search engine best practices to ensure the long-term health and authority of our domain.
Process: Once you've confirmed your interest in moving forward with the review process, we will provide a secure link for the listing/editorial fees (above) and a timeline for submission of your first draft. Following a final edit, your piece will be published and shared with our subscribers accordingly.
Terms: We reserve the right to make all publishing decisions regarding all work submitted through our review process. Please see our full terms & policies regarding the review process and publishing guest contributions as follows. By moving forward with the review process and submitting a listing/editing fee, you acknowledge and accept these terms and policies.
Guest Contribution
Terms & Policies
1. Editorial Integrity & Approval
Final Authority: Healthcare Insights (the "Publisher") maintains absolute editorial control. Submission of an article and payment of the Editorial & Listing Fee does not guarantee publication.
Standards: All content must be original, factually accurate, and free of "SEO-keyword stuffing." We reserve the right to edit for style, tone, clarity, and length.
AI Policy: Substantial use of AI-generated prose without human expertise and oversight may result in withdrawal. We value human-led "Insights."
2. Fees & Refunds
Service Fee: The Editorial & Production Fee covers the labor of peer review, fact-checking, and digital formatting.
Refunds: Once the editorial review process has begun, fees are non-refundable. If a piece is not approved for failing to meet our basic "Originality" or "Alignment" standards, a partial credit may be issued toward a future submission at the Publisher's discretion.
3. Licensing & Ownership
Non-Exclusive License: The Contributor retains the copyright to the work but grants Healthcare Insights a perpetual, royalty-free, worldwide license to publish, distribute, and index the content across its websites, social media channels, and any other digital or print platforms of distribution.
Exclusivity: We require a 14-day exclusivity window from the date of publication before the piece can be cross-posted to the Contributor’s personal blog or LinkedIn. All cross-posts must include a canonical link back to the original article on healthcarein.org.
4. Links & Search Engine Optimization (SEO)
Link Policy: To protect the domain authority of Healthcare Insights, all outbound links within "Partner Insights" will be tagged with rel="sponsored" or rel="nofollow" in compliance with Google Webmaster Guidelines.
Quantity: We allow a maximum of two (2) high-authority outbound links per Industry Perspective and three (3) per Deep-Dive.
5. Representations & Warranties
Originality: The Contributor warrants that the work is original and does not infringe upon the intellectual property rights of any third party.
Conflict of Interest: Contributors must disclose any financial interest in companies or products mentioned within the article. This will be noted at the end of the piece as a "Disclosure."
6. Termination of Content
Healthcare Insights reserves the right to remove any content at any time if the information is found to be medically inaccurate, legally defamatory, or if the Contributor’s actions bring disrepute to the Publisher’s brand.
Please direct all inquiries to editor@healthcarein.org.
OUR LATEST INSIGHTS
What policymakers frame as a cost-saving measure will be felt by scientists working on life-saving discoveries and patients who desperately need them.
“It has become clear that truth and transparency are not desired by the secretary [RFK Jr.]”, C.B.E.R. Director Peter Marks wrote in a letter to the FDA.
The new role shoulders the weight of overseeing both Medicare and Medicaid, programs that provide essential health coverage to millions of Americans.
